1. Home
  2. BBAI vs WGS Comparison

BBAI vs WGS Comparison

Compare BBAI & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BigBear.ai Inc.

BBAI

BigBear.ai Inc.

HOLD

Current Price

$3.35

Market Cap

2.2B

Sector

Technology

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$60.59

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBAI
WGS
Founded
2020
2017
Country
United States
United States
Employees
N/A
1300
Industry
EDP Services
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BBAI
WGS
Price
$3.35
$60.59
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$5.50
$130.71
AVG Volume (30 Days)
24.3M
659.3K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.89
$29.98
Revenue Next Year
$11.71
$25.92
P/E Ratio
N/A
$1,251.58
Revenue Growth
N/A
N/A
52 Week Low
$2.36
$55.17
52 Week High
$9.39
$170.87

Technical Indicators

Market Signals
Indicator
BBAI
WGS
Relative Strength Index (RSI) 40.72 36.12
Support Level $3.01 $55.18
Resistance Level $4.42 $95.75
Average True Range (ATR) 0.23 4.22
MACD 0.03 0.34
Stochastic Oscillator 44.23 32.57

Price Performance

Historical Comparison
BBAI
WGS

About BBAI BigBear.ai Inc.

BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment. Company generate revenue by providing customers with Edge AI-powered decision intelligence solutions and services for data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics and predictive visualization. It generate revenue from providing both software and services to customers.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: